Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fraction

We investigated the clinical significance of the derivative of reactive oxygen metabolites (DROM), a new marker of reactive oxygen species (ROS), in heart failure (HF) with reduced left ventricular ejection fraction (LVEF) (HFrEF) patients.

Source: Journal of Cardiac Failure - August 9, 2020 Category: Cardiology Authors: Taiki Nishihara, Takanori Tokitsu, Daisuke Sueta, Fumi Oike, Masafumi Takae, Koichiro Fujisue, Hiroki Usuku, Miwa Ito, Hisanori Kanazawa, Satoshi Araki, Yuichiro Arima, Seiji Takashio, Taishi Nakamura, Kenji Sakamoto, Satoru Suzuki, Koichi Kaikita, Eiichi Source Type: research